Postmenopausal hormone replacement therapy for chronic disease prevention: results from the Women's Health Initiative trial
- PMID: 12197697
- PMCID: PMC117857
Postmenopausal hormone replacement therapy for chronic disease prevention: results from the Women's Health Initiative trial
Comment on
-
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.JAMA. 2002 Jul 17;288(3):321-33. doi: 10.1001/jama.288.3.321. JAMA. 2002. PMID: 12117397 Clinical Trial.
References
-
- Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605-13. - PubMed
-
- Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-3. - PubMed
Publication types
LinkOut - more resources
Full Text Sources